Newtyn Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-95,000
| Closed | -$413K | – | 34 |
|
|
2024
Q3 | $413K | Hold |
95,000
| – | – | 0.06% | 38 |
|
|
2024
Q2 | $443K | Sell |
95,000
-30,000
| -24% | -$140K | 0.08% | 37 |
|
|
2024
Q1 | $634K | Sell |
125,000
-155,000
| -55% | -$786K | 0.13% | 39 |
|
|
2023
Q4 | $787K | Buy |
280,000
+75,000
| +37% | +$211K | 0.15% | 40 |
|
|
2023
Q3 | $588K | Buy |
205,000
+5,000
| +3% | +$14.4K | 0.15% | 42 |
|
|
2023
Q2 | $1.01M | Sell |
200,000
-106,609
| -35% | -$538K | 0.24% | 36 |
|
|
2023
Q1 | $579K | Sell |
306,609
-8,391
| -3% | -$15.9K | 0.11% | 68 |
|
|
2022
Q4 | $567K | Sell |
315,000
-35,000
| -10% | -$63K | 0.12% | 60 |
|
|
2022
Q3 | $592K | Sell |
350,000
-170,000
| -33% | -$288K | 0.13% | 64 |
|
|
2022
Q2 | $1.28M | Buy |
+520,000
| New | +$1.28M | 0.24% | 56 |
|